Shares

24 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2023

May 15, 2023

SELL
$0.21 - $0.35 $43,790 - $72,984
-208,526 Reduced 60.74%
134,760 $31,000
Q4 2022

Feb 14, 2023

SELL
$0.22 - $0.41 $84,000 - $156,546
-381,820 Reduced 52.66%
343,286 $84,000
Q3 2022

Nov 14, 2022

SELL
$0.41 - $0.64 $264,675 - $413,152
-645,550 Reduced 47.1%
725,106 $280,000
Q2 2022

Aug 15, 2022

BUY
$0.42 - $0.65 $575,675 - $890,926
1,370,656 New
1,370,656 $829,000
Q1 2022

May 16, 2022

SELL
$0.54 - $2.74 $54,486 - $276,466
-100,900 Closed
0 $0
Q4 2021

Feb 14, 2022

SELL
$2.33 - $3.37 $883,358 - $1.28 Million
-379,124 Reduced 78.98%
100,900 $269,000
Q3 2021

Nov 15, 2021

SELL
$2.52 - $2.99 $315,471 - $374,309
-125,187 Reduced 20.68%
480,024 $1.33 Million
Q2 2021

Aug 16, 2021

BUY
$2.6 - $3.65 $526,554 - $739,201
202,521 Added 50.29%
605,211 $1.73 Million
Q1 2021

May 17, 2021

SELL
$2.73 - $4.5 $706,584 - $1.16 Million
-258,822 Reduced 39.13%
402,690 $1.38 Million
Q4 2020

Feb 16, 2021

SELL
$2.6 - $3.32 $900,265 - $1.15 Million
-346,256 Reduced 34.36%
661,512 $1.75 Million
Q3 2020

Nov 16, 2020

SELL
$2.46 - $4.27 $386,146 - $670,261
-156,970 Reduced 13.48%
1,007,768 $3.14 Million
Q2 2020

Aug 14, 2020

BUY
$1.45 - $4.3 $872,070 - $2.59 Million
601,428 Added 106.77%
1,164,738 $4.81 Million
Q1 2020

May 14, 2020

SELL
$0.75 - $2.55 $94,529 - $321,399
-126,039 Reduced 18.28%
563,310 $907,000
Q4 2019

Feb 14, 2020

SELL
$1.65 - $2.48 $1.27 Million - $1.91 Million
-768,436 Reduced 52.71%
689,349 $1.71 Million
Q3 2019

Nov 14, 2019

SELL
$1.48 - $2.52 $195,812 - $333,411
-132,306 Reduced 8.32%
1,457,785 $2.45 Million
Q2 2019

Aug 15, 2019

BUY
$2.45 - $3.32 $3.46 Million - $4.69 Million
1,411,830 Added 792.0%
1,590,091 $3.98 Million
Q2 2019

Aug 14, 2019

SELL
$2.45 - $3.32 $1.26 Million - $1.71 Million
-514,872 Reduced 74.28%
178,261 $403,000
Q1 2019

May 14, 2019

BUY
$2.52 - $3.24 $1.24 Million - $1.59 Million
491,548 Added 243.84%
693,133 $2.13 Million
Q4 2018

Feb 14, 2019

SELL
$1.92 - $4.1 $2.64 Million - $5.63 Million
-1,373,093 Reduced 87.2%
201,585 $532,000
Q3 2018

Nov 14, 2018

BUY
$3.39 - $4.61 $609,820 - $829,283
179,888 Added 12.9%
1,574,678 $6.79 Million
Q2 2018

Aug 14, 2018

BUY
$1.89 - $4.95 $2.62 Million - $6.85 Million
1,384,237 Added 13117.0%
1,394,790 $5.5 Million
Q1 2018

May 15, 2018

BUY
$2.06 - $2.38 $21,739 - $25,116
10,553 New
10,553 $22,000
Q4 2017

Feb 14, 2018

SELL
$1.91 - $2.83 $97,929 - $145,099
-51,272 Closed
0 $0
Q3 2017

Nov 14, 2017

BUY
$2.44 - $2.91 $125,103 - $149,201
51,272
51,272 $137,000

Others Institutions Holding MEIP

# of Institutions
1
Shares Held
2K
Call Options Held
0
Put Options Held
0

About MEI Pharma, Inc.


  • Ticker MEIP
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 133,261,000
  • Market Cap $373M
  • Description
  • MEI Pharma, Inc., a late-stage pharmaceutical company, focuses on the development and commercialization of various therapies for the treatment of cancer. The company develops Zandelisib, an oral phosphatidylinositol 3-kinase delta inhibitor that is in Phase III clinical trial for the treatment of patients with relapsed/refractory follicular lymp...
More about MEIP
Track Israel Englander's Portfolio

Track Israel Englander Portfolio

Follow Israel Englander (Millennium Management LLC) and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Millennium Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Millennium Management LLC and Israel Englander with notifications on news.